Your browser doesn't support javascript.
loading
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.
Turajlic, Samra; Xu, Hang; Litchfield, Kevin; Rowan, Andrew; Horswell, Stuart; Chambers, Tim; O'Brien, Tim; Lopez, Jose I; Watkins, Thomas B K; Nicol, David; Stares, Mark; Challacombe, Ben; Hazell, Steve; Chandra, Ashish; Mitchell, Thomas J; Au, Lewis; Eichler-Jonsson, Claudia; Jabbar, Faiz; Soultati, Aspasia; Chowdhury, Simon; Rudman, Sarah; Lynch, Joanna; Fernando, Archana; Stamp, Gordon; Nye, Emma; Stewart, Aengus; Xing, Wei; Smith, Jonathan C; Escudero, Mickael; Huffman, Adam; Matthews, Nik; Elgar, Greg; Phillimore, Ben; Costa, Marta; Begum, Sharmin; Ward, Sophia; Salm, Max; Boeing, Stefan; Fisher, Rosalie; Spain, Lavinia; Navas, Carolina; Grönroos, Eva; Hobor, Sebastijan; Sharma, Sarkhara; Aurangzeb, Ismaeel; Lall, Sharanpreet; Polson, Alexander; Varia, Mary; Horsfield, Catherine; Fotiadis, Nicos.
Afiliación
  • Turajlic S; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK; Renal and Skin Units, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
  • Xu H; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Litchfield K; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Rowan A; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Horswell S; Department of Bioinformatics and Biostatistics, the Francis Crick Institute, London NW1 1AT, UK.
  • Chambers T; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • O'Brien T; Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, UK.
  • Lopez JI; Department of Pathology, Cruces University Hospital, Biocruces Institute, University of the Basque Country, Barakaldo, Spain.
  • Watkins TBK; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Nicol D; Department of Urology, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
  • Stares M; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Challacombe B; Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, UK.
  • Hazell S; Department of Pathology, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
  • Chandra A; Department of Pathology, Guy's and St. Thomas' NHS Foundation Trust, London SE1 7EH, UK.
  • Mitchell TJ; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Surgery, Addenbrooke's Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.
  • Au L; Renal and Skin Units, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
  • Eichler-Jonsson C; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Jabbar F; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Soultati A; Department of Medical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, UK.
  • Chowdhury S; Department of Medical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, UK.
  • Rudman S; Department of Medical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, UK.
  • Lynch J; Renal and Skin Units, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
  • Fernando A; Urology Centre, Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, UK.
  • Stamp G; Experimental Histopathology Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Nye E; Experimental Histopathology Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Stewart A; Department of Bioinformatics and Biostatistics, the Francis Crick Institute, London NW1 1AT, UK.
  • Xing W; Department of Scientific Computing, the Francis Crick Institute, London NW1 1AT, UK.
  • Smith JC; Department of Scientific Computing, the Francis Crick Institute, London NW1 1AT, UK.
  • Escudero M; Department of Bioinformatics and Biostatistics, the Francis Crick Institute, London NW1 1AT, UK.
  • Huffman A; Department of Scientific Computing, the Francis Crick Institute, London NW1 1AT, UK.
  • Matthews N; Advanced Sequencing Facility, the Francis Crick Institute, London NW1 1AT, UK.
  • Elgar G; Advanced Sequencing Facility, the Francis Crick Institute, London NW1 1AT, UK.
  • Phillimore B; Advanced Sequencing Facility, the Francis Crick Institute, London NW1 1AT, UK.
  • Costa M; Advanced Sequencing Facility, the Francis Crick Institute, London NW1 1AT, UK.
  • Begum S; Advanced Sequencing Facility, the Francis Crick Institute, London NW1 1AT, UK.
  • Ward S; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK; Advanced Sequencing Facility, the Francis Crick Institute, London NW1 1AT, UK; Cancer Research UK Lung Cancer Centre of Excellence London, University College London Cancer Institute, London WC1E 6DD, UK.
  • Salm M; Department of Bioinformatics and Biostatistics, the Francis Crick Institute, London NW1 1AT, UK.
  • Boeing S; Department of Bioinformatics and Biostatistics, the Francis Crick Institute, London NW1 1AT, UK.
  • Fisher R; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Spain L; Renal and Skin Units, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
  • Navas C; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Grönroos E; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Hobor S; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Sharma S; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Aurangzeb I; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, London NW1 1AT, UK.
  • Lall S; Department of Medical Oncology, Guy's and St. Thomas' NHS Foundation Trust, London SE1 9RT, UK.
  • Polson A; Department of Pathology, Guy's and St. Thomas' NHS Foundation Trust, London SE1 7EH, UK.
  • Varia M; Department of Pathology, Guy's and St. Thomas' NHS Foundation Trust, London SE1 7EH, UK.
  • Horsfield C; Department of Pathology, Guy's and St. Thomas' NHS Foundation Trust, London SE1 7EH, UK.
  • Fotiadis N; Department of Radiology, the Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
Cell ; 173(3): 595-610.e11, 2018 04 19.
Article en En | MEDLINE | ID: mdl-29656894
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido